Find a Member

Full Investigator List

Finding the right member is just a click away.

Edward Chu

Edward Chu

Program: Cancer Therapeutics 5150 Centre Avenue
Fifth Floor, Room 571
Pittsburgh PA

Dr. Edward Chu is involved in basic, clinical, and translational cancer research. His basic research interests are focused on the characterization of molecular mechanisms underlying the development of cellular drug resistance, especially as it relates to the fluoropyrimidine class of anticancer agents. His research group was the first to identify translational autoregulation as a novel regulatory mechanism in eukaryotes for controlling the expression of the folate-dependent enzymes, thymidylate synthase and dihydrofolate reductase. His clinical/translational research efforts focus on identifying novel drugs and treatment strategies for colorectal cancer and other GI cancers and in developing early phase clinical trials. He has a strong interest in integrating Chinese herbal medicine with standard cancer chemotherapy, with the goal of enhancing clinical activity and reducing toxicities.

Research Interests and Keywords
  • Colorectal cancer
  • cancer drug development
  • drug resistance
  • Chinese herbal medicine
  • early phase clinical trials
Read More about Edward Chu

View Investigators by Last Name

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z